Literature DB >> 16767494

Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer.

L Kitanovski1, J Jazbec, S Hojker, M Gubina, M Derganc.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16767494     DOI： 10.1007/s10096-006-0143-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  12 in total

1.  Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections.

Authors:  Marcello Ciaccio; Gabriella Fugardi; Lucina Titone; Amelia Romano; Salvatore Giordano; Giulia Bivona; Francesco Scarlata; Lavinia Vocca; Maria Di Gangi
Journal:  Clin Chim Acta       Date:  2004-02       Impact factor: 3.786

Review 2.  From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel.

Authors: 
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

3.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

4.  Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children.

Authors:  Glenn R Stryjewski; Eric S Nylen; Michael J Bell; Richard H Snider; Kenneth L Becker; Amy Wu; Christopher Lawlor; Heidi Dalton
Journal:  Pediatr Crit Care Med       Date:  2005-03       Impact factor: 3.624

5.  An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.

Authors:  A Engel; E Mack; P Kern; W V Kern
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 3.553

6.  C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.

Authors:  M E Santolaya; J Cofre; V Beresi
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

7.  Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.

Authors:  G Fleischhack; I Kambeck; D Cipic; C Hasan; U Bode
Journal:  Br J Haematol       Date:  2000-12       Impact factor: 6.998

8.  Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.

Authors:  Lennart Persson; Per Engervall; Anders Magnuson; Tomas Vikerfors; Bo Söderquist; Lars-Olof Hansson; Ulf Tidefelt
Journal:  Scand J Infect Dis       Date:  2004

9.  Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study.

Authors:  H Giamarellou; E J Giamarellos-Bourboulis; P Repoussis; L Galani; N Anagnostopoulos; P Grecka; D Lubos; M Aoun; K Athanassiou; E Bouza; E Devigili; V Krçmery; F Menichetti; E Panaretou; E Papageorgiou; D Plachouras
Journal:  Clin Microbiol Infect       Date:  2004-07       Impact factor: 8.067

10.  Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia.

Authors:  Antonio Jimeno; Adelaida García-Velasco; Olga del Val; Enrique González-Billalabeitia; Susana Hernando; Rosario Hernández; Alfonso Sánchez-Muñoz; Ana López-Martín; Ignacio Durán; Luis Robles; Hernán Cortés-Funes; Luis Paz-Ares
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860
View more
  16 in total

1.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

Review 2.  Biomarkers for pediatric sepsis and septic shock.

Authors:  Stephen W Standage; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

Review 3.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

4.  The ubiquitous interleukin-6: a time for reappraisal.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2010-10-11       Impact factor: 9.951

Review 5.  Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.

Authors:  Robert S Phillips; Ros Wade; Thomas Lehrnbecher; Lesley A Stewart; Alex J Sutton
Journal:  BMC Med       Date:  2012-01-18       Impact factor: 8.775

6.  Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.

Authors:  Victoria Hemming; Adam D Jakes; Geoff Shenton; Bob Phillips
Journal:  BMC Pediatr       Date:  2017-01-05       Impact factor: 2.125

7.  Clinicohematological Profile of Febrile Neutropenia in Childhood Acute Leukemia and Utility of Serum Procalcitonin Levels in Neutropenic Patients.

Authors:  Rajan Kapoor; Ashish K Simalti; Shuvendu Roy; Pulkit Agarwal
Journal:  Indian J Crit Care Med       Date:  2018-05

Review 8.  Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).

Authors:  Robert S Phillips; Alex J Sutton; Richard D Riley; Julia C Chisholm; Susan V Picton; Lesley A Stewart
Journal:  Syst Rev       Date:  2012-02-09

9.  Performance of Interleukin-6 and Interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk.

Authors:  Miriam Diepold; Peter Noellke; Ulrich Duffner; Udo Kontny; Reinhard Berner
Journal:  BMC Infect Dis       Date:  2008-03-06       Impact factor: 3.090

10.  Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.

Authors:  Hilde T van der Galiën; Erik A H Loeffen; Karin G E Miedema; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2018-05-19       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.